Tag: Processa Pharmaceuticals Inc.

Technologies

Processa Pharmaceuticals Inc (NASDAQ:PCSA) Stock Plunged -66.06% So Far In 2025, What Analysts Expect Next?

In last trading session, Processa Pharmaceuticals Inc (NASDAQ:PCSA) saw 50.61 million shares changing hands with its beta currently measuring 1.31. Company’s recent per share price

Business

Processa Pharmaceuticals Inc (PCSA) Shares Are Down -62.83% YTD

Processa Pharmaceuticals Inc (NASDAQ:PCSA) has a beta value of 1.31 and has seen 44.44 million shares traded in the recent trading session. The company, currently

Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.

Tag: Processa Pharmaceuticals Inc.

Processa Pharmaceuticals Inc (NASDAQ:PCSA) Stock Plunged -66.06% So Far In 2025, What Analysts Expect Next?

Processa Pharmaceuticals Inc (PCSA) Shares Are Down -62.83% YTD

Quick Links

Categories